Gland Pharma Limited — Others, 08-02-2025: Copy of Newspaper Publication

Gland Pharma Limited has announced a board meeting to discuss a postal ballot, with the primary resolutions focusing on commission on profits as remuneration for three independent directors. E-voting will commence on February 8, 2025, and conclude on March 9, 2025. The results will be declared by March 11, 2025.

This move indicates a proactive approach to governance and aligns management incentives with company performance. Investors may view this as a positive outlook for governance practices, though it's crucial to monitor how these compensation changes affect overall financial health and shareholder value.